The inaugural symposium brought together leading healthcare providers, payers and manufacturers of high-cost, ultra-specialty pharmaceuticals to discuss the promise the rapidly expanding market of cell, gene and other advanced therapies.
This is Vizient’s third time being named to this prestigious list. Earning a spot means that Vizient is one of the best companies to work for in the country.
The recommendations focus on appropriate communication, secure access, management of critically ill patients who are unable to run, hide and fight, and include tactics for addressing post-event trauma.
Vizient, Inc. submitted comments to the Food and Drug Administration on the development of a program aimed at promoting drug manufacturers’ quality management maturity.
The latest Medical Device Tech Watch assesses new technology to combat atrial fibrillation and offers a glimpse of how artificial intelligence will help process remote monitoring data.
Yesterday on Capitol Hill, Vizient, Inc. held a policy briefing titled, “Communities in Crisis: How Hospitals are Addressing Mental and Behavioral Health Challenges in their Communities” at the Rayburn House Office Building.
Vizient responds to Centers for Medicare and Medicaid Services’ (CMS) final remedy for its unlawful 340B payment cuts from 2018 through a majority of 2022.
Vizient today announced it has completed its acquisition of PrefTech OR, a next-generation, cloud-based preference card management software that helps healthcare providers optimize their operating rooms to increase workflow efficiency, lower costs and impr...
This is Vizient’s second year in a row to be named to this prestigious list, and it means that Vizient is one of the best companies to work for in the country.
Vizient, Inc. offered feedback in response to the Administration’s proposed rule on updating requirements for the Mental Health Parity and Addiction Equity Act of 2008.
Vizient, Inc. offered feedback in response to the House Ways and Means Committee's Request for Information on improving healthcare in rural and underserved areas.
The awards recognize the work of Vizient provider customers in clinical quality and accountability, supplier diversity and environmentally preferred sourcing excellence and were presented during the 2023 Vizient Connections Summit in Las Vegas.
Vizient presented the awards at its annual Connections Summit in Las Vegas to recognize suppliers and distributors for delivering exceptional service to Vizient customer providers.
Vizient, Inc. pharmacy experts will speak at the Food and Drug Administration’s (FDA) Compounding Quality Center of Excellence 2023 Virtual Conference on September 12-13.
Vizient, Inc. submitted comments on the Centers for Medicare and Medicaid Services (CMS) CY 2024 Medicare Hospital Outpatient Prospective Payment System (OPPS) and Physician Fee Schedule (PFS) proposed rules.